Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE7500
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM181589
GPL570
Group 1 replicate scramble siRNA no RA NT2 cells with scramble siRNA no RA Human embryonal carcinoma cells tranfected with scramble siRNA from Dharmacon and then treated with vehicle (DMSO) see above
GSM181754
GPL570
Group 1 replicate RISC-free siRNA from Dharmacon no RA NT2 cells with RISC-free siRNA no RA Human embryonal carcinoma cells, NT2/D1 transfected with RISC-Free siRNA and treated for 24 hours with vehicle (DMSO) see above
GSM181755
GPL570
Group 1 replicate 2 RISC-free siRNA from Dharmacon no RA NT2 cells with RISC-free siRNA no RA human embryonal carcinoma cells tranfected with RISC-free darmacon siRNA and then treated with vehicle (DMSO) see above
GSM181757
GPL570
Group 3 siRNA#2 for RIP140 no RA NT2 cells with RIP140 siRNA#2 no RA human embyonal carcinoma, NT2/D1 cell line tranfected with RIP140 siRNA#2 and treated with vehicle (DMSO) see above
GSM181758
GPL570
Group 3 siRNA#3 for RIP140 no RA NT2 cells with RIP140 siRNA#3 no RA human embyonal carcinoma, NT2/D1 cell line tranfected with RIP140 siRNA#3 and treated with vehicle (DMSO) see above
GSM181759
GPL570
Group 2 scramble siRNA from Dharmacon treated with RA NT2 cells with scramble siRNA treated with RA human embyonal carcinoma, NT2/D1 cell line tranfected with scrambled II siRNA and treated with 10 uM retinoic acid (RA) for 24 hours see above
GSM181760
GPL570
Group 2 RISC-free siRNA from Dharmacon treated with RA NT2 cells with RISC-free siRNA with RA human embyonal carcinoma, NT2/D1 cell line tranfected with RISC-free siRNA and treated with 10 uM retinoic acid (RA) for 24 hours see above
GSM181761
GPL570
Group 4 siRNA#1 for RIP140 with RA nT2 cells with RIP140 siRNA#1 with RA human embyonal carcinoma, NT2/D1 cell line tranfected with RIP140 siRNA#1 and treated with 10 uM retinoic acid (RA) for 24 hours see above
GSM181762
GPL570
Group 4 siRNA#2 for RIP140 with RA nT2 cells with RIP140 siRNA#2 with RA human embyonal carcinoma, NT2/D1 cell line tranfected with RIP140 siRNA#2 and treated with 10 uM retinoic acid (RA) for 24 hours see above
GSM181763
GPL570
Group 4 siRNA#3 for RIP140 with RA nT2 cells with RIP140 siRNA#3 with RA human embyonal carcinoma, NT2/D1 cell line tranfected with RIP140#3 siRNA and treated with 10 uM retinoic acid (RA) for 24 hours see above
GSM181764
GPL570
Group 2 RISC-free replicate siRNA with RA nT2 cells with RISC-free siRNA with RA human embyonal carcinoma, NT2/D1 cell line tranfected with RISC-free siRNA and treated with 10 uM retinoic acid (RA) for 24 hours see above
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes